Does EVOLOCUMAB Cause Hypersensitivity? 954 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 954 reports of Hypersensitivity have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.6% of all adverse event reports for EVOLOCUMAB.
954
Reports of Hypersensitivity with EVOLOCUMAB
0.6%
of all EVOLOCUMAB reports
3
Deaths
82
Hospitalizations
How Dangerous Is Hypersensitivity From EVOLOCUMAB?
Of the 954 reports, 3 (0.3%) resulted in death, 82 (8.6%) required hospitalization, and 6 (0.6%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for EVOLOCUMAB.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which EVOLOCUMAB Alternatives Have Lower Hypersensitivity Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE